Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05758532 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05758532 · ClinicalTrials.gov record · last posted 2024-05-29

Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children

Study acronym: NEMAU
StatusRecruiting
PhasePhase 4
Started2023-03-17
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 29, 2024 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
The goal of this clinical trial is to evaluate the off-target/non-specific effects of the measles-mumps-rubella (MMR) vaccine in children.

Amendment record 2 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 2 times since 2023-02-24; most recent amendment 2024-05-27. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2023-03-22
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT05758532
Lead Sponsor Laure Pittet, MD-PhD
Conditions Respiratory Tract Infections, Infections, Allergy, Eczema
Enrollment 500 participants
Start Date 2023-03-17
Primary Completion 2026-04 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-05-29